Patent · US Active

Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

US7563798B2 · kind B2 · utility

11Cited by

0References

3Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Timothy J. Guzi · Chatham, US
Kamil Paruch · Garwood, US
Michael P. Dwyer · Scotch Plains, US
M. Arshad Siddiqui · Newton, US
Panduranga Adulla P. Reddy · Walpole, US
David B. Belanger · Cambridge, US
Blake Hamann · Linthicum, US
Patrick J. Curran · Saugus, US

Key dates

Filing date	Oct 4, 2006
Grant date	Jul 21, 2009
Priority date	—
Expiry date	May 11, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In its many embodiments, the present invention provides a class of pyrazolo [1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases (CDKs), methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. An illustrative compound of the invention is shown below:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.